...
机译:探索松弛素3的功能域,并在松弛素受体RXFP1 / LGR7上建立RXFP3 / GPCR135的选择性拮抗剂。
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Howard Florey Institute, University of Melbourne, Victoria 3010, Australia;
Howard Florey Institute, University of Melbourne, Victoria 3010, Australia;
Howard Florey Institute, University of Melbourne, Victoria 3010, Australia;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., San Diego, California 92121, USA;
relaxin-3; INSL5; relaxin; GPCR135; RXFP3; GPCR142; RXFP4; GPR100; LFR7; RXFP1;
机译:最小化人类Relaxin-3导致高亲和力类似物,与RXFP1相比,对松弛素家族肽3受体(RXFP3)的选择性增加
机译:Relaxin-3受体(RXFP3)基因敲除小鼠显示减少的运行轮活动:对持续唤醒中的休闲素-3 / RxFP3信号传导的影响
机译:在松弛素3和受体选择性肽急性和慢性激活RXFP3后大鼠中进食和体重增加的增加:功能和治疗意义
机译:双官能肽的设计与合成:Ccka / Cckb受体的拮抗剂和穆/δ阿片受体的激动剂
机译:促肾上腺皮质激素释放因子受体跨膜结构域3和5中特定氨基酸残基对CRF-r1选择性小分子拮抗剂功能活性的重要性
机译:松弛素3受体RXFP3上单链肽拮抗剂的结合构象和决定因素
机译:弛豫素-3的差异效应和选择性松弛素-3受体激动剂对大鼠食品和水摄入和下丘脑神经元活性的影响